News
5mon MSN
Notable healthcare headlines for the week: Pfizer, UnitedHealth, Sarepta and Thermo Fisher in focus
Currently, a multidistrict litigation against Pfizer (NYSE: PFE) is underway on behalf of women who claim to have developed meningiomas after receiving four or more consecutive injections of ...
Waystar to acquire Iodine Software for $1.25 billion to enhance AI tools; deal expected to be accretive to growth and margins by 2027.
This stock is worth watching for several compelling reasons, including a gamechanging acquisition, ahead of its upcoming earnings.
Thank you, John, and good afternoon, everyone. It is my pleasure to welcome you to Waystars' Investor conference call. Matt Hawkins, Waystar's Chief Executive Officer; and Steven Oreskovich, Waystar's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results